SCHEMBL10093008

SCHEMBL10093008

Cc1ccc(C(=O)c2c(C)n(CCN3CCOCC3)c3ccc(O)cc23)c2ccccc12

nearest known ligand 0.83

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 2/20 0.64
CNR1 P21554 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10093006 0.93 CNR1 (0.63) CNR2CNR1
SCHEMBL15142718 0.91 CNR2 (0.66) CNR2CNR1
SCHEMBL10093007 0.91 CNR2 (0.77) CNR2CNR1
SCHEMBL670677 0.90 CNR1 (0.63) CNR2CNR1
SCHEMBL670365 0.88 CNR1 (0.68) CNR2CNR1
SCHEMBL15142732 0.86 CNR1 (0.64) CNR2CNR1
SCHEMBL9691568 0.86 CNR1 (0.64) CNR2CNR1
SCHEMBL10093009 0.85 CNR1 (0.62) CNR2CNR1
SCHEMBL10093012 0.83 CNR1 (0.67) CNR2CNR1
SCHEMBL15126358 0.83 CNR1 (0.62) CNR2CNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012024670-A2 COMPOSITION AND METHODS FOR TREATING GLIOBLASTOMA UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION (US) 2012-02-23 WO disclosed